Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Thomson Medical Group Ltd. ( (SG:A50) ) just unveiled an announcement.
Thomson Medical Group has appointed entrepreneur and veteran corporate leader Tong Kooi Ong as Chairman of the Board with effect from 1 February 2026, replacing Ng Ser Miang, who steps down after nearly a decade in the role. The board transition comes as the group moves into its next phase of growth, with management highlighting Tong’s track record in large-scale, capital-intensive developments and his extensive regional business networks as critical assets for advancing Thomson Medical’s leadership in the healthcare sector, including the ambitious Johor Bay project in the Johor–Singapore Special Economic Zone.
The most recent analyst rating on (SG:A50) stock is a Hold with a S$0.06 price target. To see the full list of analyst forecasts on Thomson Medical Group Ltd. stock, see the SG:A50 Stock Forecast page.
More about Thomson Medical Group Ltd.
Thomson Medical Group Limited is a Singapore-based healthcare provider listed on the SGX Mainboard, with a strong presence in Southeast Asia. The group focuses on women’s and children’s health, fertility services and multi-disciplinary care, and has expanded from its Singapore roots into a leading regional healthcare player with growing capabilities and a widening footprint.
YTD Price Performance: 5.00%
Average Trading Volume: 6,358,072
Technical Sentiment Signal: Buy
Current Market Cap: S$1.67B
For detailed information about A50 stock, go to TipRanks’ Stock Analysis page.